Safety profiles of methylphenidate, amphetamine, and atomoxetine: analysis of spontaneous reports submitted to the food and drug administration adverse event reporting system

• Autors principals: Wei Wei (Autor), Li Chen (Autor), Hui Zhou (Autor), Jinfeng Liu (Autor), Yue Zhang (Autor), Shiyu Feng (Autor), Yingtao Bai (Autor), Yanen Leng (Autor), En Chang (Autor), Liang Huang (Autor)
• Format: Llibre
• Publicat: Frontiers Media S.A., 2023-08-01T00:00:00Z.
• Matèries: article
• Accés en línia: Connect to this object online.

Background: Methylphenidate, atomoxetine, and Amphetamine are the three most commonly used medications approved by the United States Food and Drug Administration (FDA) for the treatment of attention deficit/hyperactivity disorder (ADHD). However, a comprehensive analysis of their safety profiles acr...